Navigation Links
USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
Date:1/29/2008

Eliminates the Need for Translation of Compendia Used to Ensure the Quality of Pharmaceutical and Over-the-Counter Medications

ROCKVILLE, Md., Jan. 29 /PRNewswire-USNewswire/ -- The U.S. Pharmacopeia is pleased to announce that the third annual Spanish edition of its core compendia, the United States Pharmacopeia and National Formulary (USP-NF), is now available for purchase. The official edition for 2008, USP 31-NF 26, provides specifications needed to produce more than 4,000 quality pharmaceuticals, excipients, dietary supplements, biologics and other therapeutics.

USP-NF, recognized by U.S. federal law as the country's official compendia for drug standards, offers access to monographs defining the required standards for the identity, quality, purity, strength, labeling and packaging for pharmaceutical and over-the-counter medications, dietary supplements, and other health care products. These standards are enforceable by the U.S. Food and Drug Administration for drugs marketed in or exported to the United States, and are also recognized by governments and regulatory agencies throughout the world.

"USP is proud to offer a Spanish edition of the USP-NF for the third year in a row," said Darrell Abernethy, M.D., Ph.D., chief science officer of USP. "By translating the compendia, we hope to better meet the needs of our Spanish-speaking partners as we work together to advance USP's mission of providing good pharmaceutical care for all people, all over the world."

The Spanish edition is an official, expert translation of the USP-NF in English. Written in a universal, neutral Spanish, the translation process is supervised by USP's Spanish Advisory Panel -- a dedicated body of leading scientific experts from Spanish-speaking countries. USP offers expert scientific and technical support in Spanish during business hours that are convenient for Spanish-speaking customers.

USP-NF is used by quality assurance and quality con
'/>"/>

SOURCE U.S. Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
2. American College of Physicians publishes The Fenway Guide to LGBT Health
3. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
4. Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis
5. American College of Physicians publishes "Peripheral Arterial Disease"
6. Thomson Scientific Publishes Who Is Making The Biggest Splash? - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
7. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
8. The Endocrine Society Publishes White Paper Calling for Greater Minority Participation in Clinical Research
9. Springer publishes La Chirurgia degli Organi de Movimento
10. The Diabetes Educator publishes systematic reviews for diabetes management
11. Latin American adolescents are more likely to become infected with HIV than Spanish
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... In an effort to provide the twenty four ... a change in his practice. , The decision will also allow him to spend ... will be transferring his in-patient admissions to the hospitalists at East Liverpool City Hospital.Dr. ...
(Date:7/30/2015)... FL (PRWEB) , ... July 30, 2015 , ... ... software, TikiLIVE, has worked to protect victims in San Diego, California’s Gaslamp Quarter ... used by Gaslamp Quarter Plaza actively monitor the area for any suspicious ...
(Date:7/30/2015)... ... ... " DevExpress ” was featured on NewsWatch as part ... large businesses making an impact in their industry. Susan Bridges, a reporter for ... how DevExpress has provided software development tools that have helped app developers build ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Beryl Institute announces ... In partnership with Patient Experience Institute, these offerings reinforce the commitment to help ... lines and throughout the experience movement, and provide information and research to support ...
(Date:7/30/2015)... Newport Beach, California (PRWEB) , ... July 30, ... ... products and services, announced today that the latest issue of Inclusive™ magazine, its ... multiple digital platforms. The digital edition of the new issue, Volume 6, Issue ...
Breaking Medicine News(10 mins):Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4
... North Carolina law firm sponsors bicycle safety video public service announcement ... ... February 17, 2009 -- HensonFuerst is giving local teens the chance ... announcement (PSA) contest in eastern North Carolina this spring. The mission ...
... CHICAGO, Feb. 17 While the common perception about ... is that it,s a rich person,s game, a Chicago ... eight years that we,ve been matching surrogates with our ... personal sacrifices. And nobody,s ever shown regret," says Robin ...
... Angeles Jewish Home are in it for the , Long ... Feb. 17 At the Los Angeles Jewish Home, one ... roof in the U.S. all agree on two things: They ... have the best ideas on just how to accomplish that ...
... Brighter smiles await,children in the Los Angeles area ... Oral Health Improvement Program to the La Canada,and Pacoima ... (Logo: http://www.newscom.com/cgi-bin/prnh/20011026/BIGLOTSLOGO ) , ... Smiles, Bright Futures dental van and its team,of dental ...
... that blocking the activity of a protein in the blood ... the study, normal mice and mice that had a genetically ... ultraviolet light that mimics chronic sun exposure. The mice that ... vascular skin cancer tumors than did the normal mice. , ...
... Michael Marmot, chair of the World Health Organization ... of the International Institute for Society and Health ... Positive Health Lecture Series talk, "Social Determinants of ... Health Lecture Series is organized by Martin Seligman, ...
Cached Medicine News:Health News:HensonFuerst Invites North Carolina Teens to Make Their Directorial Debuts 2Health News:The Surrogacy Journey: Not Just For the Wealthy 2Health News:Unique Group of 90-Year-Olds Share Top Ten Longevity Tips 2Health News:Unique Group of 90-Year-Olds Share Top Ten Longevity Tips 3Health News:Colgate's Bright Smiles, Bright Futures Program Brings Free Children's Dental Screenings to Los Angeles Area Big Lots Stores 2Health News:Blocking protein leads to fewer, smaller skin cancer tumors 2Health News:Blocking protein leads to fewer, smaller skin cancer tumors 3Health News:Blocking protein leads to fewer, smaller skin cancer tumors 4
(Date:7/30/2015)... July 30, 2015 Future Market ... titled, "Continuous Glucose Monitoring Systems Market: Global Industry Analysis ... report, the global continuous glucose monitoring systems market was ... expected to reach US$ 788.4 Mn by 2020, registering ... to 2020. Global continuous glucose monitoring systems ...
(Date:7/30/2015)... 2015 Vermillion, Inc. (VRML), a ... announced today it will report its second ... close on Thursday, August 13, 2015, followed ... at 4:30pm Eastern.Conference Call and Webcast:  ... Pacific  Domestic: , 888-430-8691International: ...
(Date:7/30/2015)... , July 30, 2015  NanoSmart Pharmaceuticals, Inc., ... platforms, has received Orphan Drug Designation from the ... drug product that uses NanoSmart,s proprietary drug delivery ... dactinomycin for the treatment of Ewing,s sarcoma, a ... granted NanoSmart,s Orphan Drug Designation on the basis ...
Breaking Medicine Technology:Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2
... 11 Phosphagenics,Limited ("Phosphagenics") (ASX: POH; AIM: PSG; ... their joint phase 2 human clinical,trial to establish ... of metabolic syndrome is advancing at three sites ... of study participants, the,double-blind phase 2 trial, which ...
... Feb. 11 ,Pharmion (Nasdaq: PHRM ) and ... Medicines Agency (EMEA) and the European Commission (EC),designated ... Orphan,Medicinal Product for the treatment of acute myelogenous ... require that the product be,intended for the treatment ...
Cached Medicine Technology:Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 2Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 4Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 3Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 4
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
The ALB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of albumin in serum...
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
Medicine Products: